ANVS Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Annovis Bio Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 6.11 USD 9.69%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast ANVS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ANVS is 36.11 USD with a low forecast of 13.13 USD and a high forecast of 75.6 USD.

ANVS Lowest Forecast

Wall Street Target

ANVS Average Forecast

Wall Street Target

ANVS Highest Forecast

Wall Street Target

115% Upside

491% Upside

1 137% Upside

The latest public price target was made on Apr 30, 2024 by Sumant Kulkarni from Canaccord Genuity , who expects ANVS stock to rise by 326% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst	Price Target	Date	Article
Sumant Kulkarni Canaccord Genuity	26 USD Upside 326%	2 days ago Apr 30, 2024	Annovis Bio price target lowered to $26 from $36 at Canaccord TheFly

Price Target	26 USD
Upside/Downside	326%

China Resources Boya Bio pharmaceutical Group Co Ltd

9% Upside

Neurocrine Biosciences Inc

8% Upside

Shanghai RAAS Blood Products Co Ltd

25% Upside

Transcenta Holding Limited

364% Upside

China Resources Boya Bio pharmaceutical Group Co Ltd

9% Upside

Neurocrine Biosciences Inc

8% Upside

Shanghai RAAS Blood Products Co Ltd

25% Upside

Transcenta Holding Limited

364% Upside

Inventiva SA

279% Upside

Guangdong Hybribio Biotech Co Ltd

540% Upside

Avacta Group PLC

101% Upside

TMS Co Ltd

187% Upside

Revenue
Forecast

N/A

N/A

N/A

N/A

What are analyst estimates?

Operating Income
Forecast

N/A

N/A

-6%

What are analyst estimates?

Net Income
Forecast

N/A

N/A

-7%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for ANVS is 36.11 USD with a low forecast of 13.13 USD and a high forecast of 75.6 USD.

Join more than 133,300+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.